Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
19217 | 450 | 23.7 | 72% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
233 | 19645 | BONE MARROW TRANSPLANTATION//GRAFT VERSUS HOST DISEASE//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TRANSPLANT RATES | Author keyword | 34 | 93% | 3% | 13 |
2 | EBMT ACT SURVEY OFF | Address | 15 | 77% | 2% | 10 |
3 | OPERAT COMPUTAT FINANCE | Address | 9 | 67% | 2% | 8 |
4 | EBMT SECRETARIAT | Address | 8 | 75% | 1% | 6 |
5 | JACIE OFF | Address | 6 | 100% | 1% | 4 |
6 | TRANSPLANT ACTIVITY | Author keyword | 5 | 63% | 1% | 5 |
7 | EBMT ACTIV SURVEY OFF | Address | 4 | 75% | 1% | 3 |
8 | OPERAT COMPUTAT FINANCES | Address | 3 | 100% | 1% | 3 |
9 | OUTPATIENT TRANSPLANT | Author keyword | 3 | 100% | 1% | 3 |
10 | TRANSPLANT ACT SURVEY OFF | Address | 3 | 100% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TRANSPLANT RATES | 34 | 93% | 3% | 13 | Search TRANSPLANT+RATES | Search TRANSPLANT+RATES |
2 | TRANSPLANT ACTIVITY | 5 | 63% | 1% | 5 | Search TRANSPLANT+ACTIVITY | Search TRANSPLANT+ACTIVITY |
3 | OUTPATIENT TRANSPLANT | 3 | 100% | 1% | 3 | Search OUTPATIENT+TRANSPLANT | Search OUTPATIENT+TRANSPLANT |
4 | OUTPATIENT TRANSPLANTATION | 3 | 60% | 1% | 3 | Search OUTPATIENT+TRANSPLANTATION | Search OUTPATIENT+TRANSPLANTATION |
5 | HEMATOPOIETIC SCT | 3 | 14% | 4% | 17 | Search HEMATOPOIETIC+SCT | Search HEMATOPOIETIC+SCT |
6 | PHYSICIAN CAPACITY | 2 | 67% | 0% | 2 | Search PHYSICIAN+CAPACITY | Search PHYSICIAN+CAPACITY |
7 | STEM CELL SOURCE | 2 | 28% | 1% | 5 | Search STEM+CELL+SOURCE | Search STEM+CELL+SOURCE |
8 | NOVEL CELLULAR THERAPIES | 1 | 100% | 0% | 2 | Search NOVEL+CELLULAR+THERAPIES | Search NOVEL+CELLULAR+THERAPIES |
9 | TEAM DENSITY | 1 | 100% | 0% | 2 | Search TEAM+DENSITY | Search TEAM+DENSITY |
10 | UNRELATED TRANSPLANTS | 1 | 33% | 0% | 2 | Search UNRELATED+TRANSPLANTS | Search UNRELATED+TRANSPLANTS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HIGH DOSE REGIMENS | 26 | 100% | 2% | 11 |
2 | PANCYTOPENIC PHASE | 5 | 60% | 1% | 6 |
3 | PROTECTIVE ISOLATION | 4 | 34% | 2% | 10 |
4 | JACIE ACCREDITATION | 1 | 100% | 0% | 2 |
5 | HEMATOLOGICAL DISEASES | 1 | 20% | 1% | 6 |
6 | EBMT ACTIVITY SURVEY | 1 | 27% | 1% | 4 |
7 | EBMT | 1 | 12% | 2% | 9 |
8 | CELL TRANSPLANTS | 1 | 20% | 1% | 5 |
9 | HIDDEN FINANCIAL COSTS | 1 | 40% | 0% | 2 |
10 | PBPC | 1 | 17% | 1% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Costs and Cost-Effectiveness of Hematopoietic Cell Transplantation | 2012 | 11 | 26 | 81% |
Economic burden of acute myeloid leukemia: a literature review | 2004 | 30 | 24 | 67% |
Why are there regional differences in stem cell transplantation activity? An EBMT analysis | 2008 | 11 | 6 | 83% |
Hematopoietic stem cell transplantation activity in Europe | 2013 | 11 | 33 | 39% |
JACIE: from guidelines to clinical practice and continuous quality improvement, the Leon-Berard cancer center experience | 2009 | 3 | 1 | 100% |
Hematopoietic Stem Cell Transplantation in Southern Iran: History, Current Status and Future Direction | 2009 | 8 | 26 | 69% |
Swiss Blood Stem Cells: More than Just a Registry | 2011 | 1 | 1 | 100% |
Turkish transplant registry: a comparative analysis of national activity with the EBMT European Activity Survey | 2008 | 0 | 6 | 100% |
A review of the costs, cost-effectiveness and third-party charges of bone marrow transplantation | 1996 | 14 | 6 | 83% |
Optimizing Quality and Efficiency of Healthcare Delivery in Hematopoietic Cell Transplantation | 2015 | 0 | 16 | 69% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EBMT ACT SURVEY OFF | 15 | 77% | 2.2% | 10 |
2 | OPERAT COMPUTAT FINANCE | 9 | 67% | 1.8% | 8 |
3 | EBMT SECRETARIAT | 8 | 75% | 1.3% | 6 |
4 | JACIE OFF | 6 | 100% | 0.9% | 4 |
5 | EBMT ACTIV SURVEY OFF | 4 | 75% | 0.7% | 3 |
6 | OPERAT COMPUTAT FINANCES | 3 | 100% | 0.7% | 3 |
7 | TRANSPLANT ACT SURVEY OFF | 3 | 100% | 0.7% | 3 |
8 | HEMATOL ONCOL SCT | 3 | 60% | 0.7% | 3 |
9 | ACUTE LEUKEMIA WORKING PARTY EBMT | 2 | 67% | 0.4% | 2 |
10 | INTERNAL AUDITING | 2 | 67% | 0.4% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000192862 | FACT BMT//PEDIATRIC SCT//PSYCHOL CONSULTAT LIAISON PSYCHIAT |
2 | 0.0000157396 | HAPLOIDENTICAL//NORMAL DONORS//T CELL DEPLETION |
3 | 0.0000136065 | PLERIXAFOR//LARGE VOLUME LEUKAPHERESIS//STEM CELL MOBILIZATION |
4 | 0.0000134397 | REDUCED INTENSITY CONDITIONING//DONOR LYMPHOCYTE INFUSION//REDUCED INTENSITY |
5 | 0.0000131645 | INT TRANSPLANTAT THALASSEMIA SICKLE CELL AN//MEDITERRANEAN HEMATOL//TR IANTO MIDOLLO OSSEO MURAGLIA |
6 | 0.0000125338 | GENITAL GVHD//CARDIAC LATE EFFECTS//HCT HEMATOPOIETIC CELL TRANSPLANTATION |
7 | 0.0000091403 | CORD BLOOD TRANSPLANTATION//UMBILICAL CORD BLOOD//CORD BLOOD |
8 | 0.0000075113 | ACUTE MYELOID LEUKEMIA//GEMTUZUMAB OZOGAMICIN//AML |
9 | 0.0000073005 | BUSULFAN//TREOSULFAN//INTRAVENOUS BUSULFAN |
10 | 0.0000070785 | FEBRILE NEUTROPENIA//NEUTROPENIA//NEUTROPENIC FEVER |